A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above
Clinical trial NCT05198596 · COMPLETED
Trial details
- NCT number
- NCT05198596
- Sponsor
- Medigen Vaccine Biologics Corp.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-30
- Primary completion
- 2022-11-04
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.